Jennifer L Sloan

Title: Jennifer L Sloan: Innovator in Gene Therapy

Introduction

Jennifer L Sloan is a prominent inventor based in Silver Spring, MD (US). She has made significant contributions to the field of gene therapy, particularly in addressing metabolic disorders. Her work focuses on innovative solutions for conditions such as combined methylmalonic acidemia and hyperhomocysteinemia.

Latest Patents

Jennifer holds a patent for her invention titled "Gene therapy for combined methylmalonic acidemia/aciduria and hyperhomocysteinemia/homocystinuria, cobalamin C type, and deficiency of MMACHC." This patent provides a synthetic MMACHC polynucleotide that is codon-optimized for expression in humans. Additionally, it includes a polypeptide encoded by the synthetic MMACHC polynucleotide, an expression vector with a MMACHC gene sequence controlled by a chicken beta actin promoter, and methods for treating cobalamin C deficiency.

Career Highlights

Jennifer is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. Her work has been instrumental in advancing gene therapy techniques and improving treatment options for patients with specific metabolic disorders.

Collaborations

Jennifer collaborates with Charles P Venditti, enhancing the research and development of innovative therapies in her field.

Conclusion

Jennifer L Sloan's contributions to gene therapy exemplify her commitment to advancing medical science and improving patient outcomes. Her innovative work continues to pave the way for new treatments in metabolic disorders.